Veris Residential (VRE) Rule 144 Notice Shows Multiple September 2025 Dispositions

Rhea-AI Filing Summary

Veris Residential, Inc. (VRE) notice reports a proposed sale of 20,097 common shares by a person who acquired those shares in the open market on 11/21/2018 and paid cash on 11/23/2018. The sale is to be executed through Morgan Stanley Smith Barney LLC on the NYSE with an aggregate market value listed at $311,909.46 and an approximate sale date of 09/17/2025. The filing also lists multiple common-share dispositions during September 2025 by related entities MIRELF VII US SECURITIES LLC and MIRELF VI REIT INVESTMENT II, LLC, showing individual sale amounts and gross proceeds, indicating active secondary selling by those entities.

Positive

• None.

Negative

• Proposed sale of 20,097 shares valued at $311,909.46 to be executed on 09/17/2025 through Morgan Stanley may add supply to the market.
• Multiple large dispositions in September 2025 by MIRELF VII US SECURITIES LLC and MIRELF VI REIT INVESTMENT II, LLC are listed, with individual transactions showing significant gross proceeds.

Insights

Securities Analyst

TL;DR Significant scheduled and recent block sales of VRE common shares by related entities may increase available supply in the near term.

The filing documents a proposed sale of 20,097 shares valued at $311,909.46 to be executed through Morgan Stanley on 09/17/2025. The record of numerous recent dispositions by MIRELF VII and MIRELF VI shows large daily blocks and material gross proceeds, demonstrating active liquidation by those entities over multiple September dates. From a market perspective, clustered selling from affiliated holders can pressure near-term liquidity and price discovery. This notice is procedural compliance with Rule 144 and provides transparent timing and execution details.

Corporate Governance Expert

TL;DR Filing is a routine Rule 144 disclosure but highlights concentrated secondary sales by affiliated entities.

The form confirms the seller represents there is no undisclosed material adverse information and discloses acquisition and payment details for the 20,097 shares sold. The inclusion of many large sales by MIRELF VII US SECURITIES LLC and MIRELF VI REIT INVESTMENT II, LLC in September 2025 is notable from an ownership-transparency standpoint. While the filing does not state insider status or intent beyond the sales, the frequency and scale of disposals merit attention from governance and disclosure monitors.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	20097	311909.46	93421769	09/17/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/21/2018	Open Market Purchase	Open Market			20097	11/23/2018	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
MIRELF VII US SECURITIES LLC Harborside 3, 210 Hudson St. Ste. 400 Jersey City NJ 07311	Common	09/16/2025	54108	834784.42
MIRELF VI REIT INVESTMENT II, LLC Harborside 3, 210 Hudson St. Ste. 400 Jersey City NJ 07311	Common	09/16/2025	40355	622601.54
MIRELF VI REIT INVESTMENT II, LLC Harborside 3, 210 Hudson St. Ste. 400 Jersey City NJ 07311	Common	09/15/2025	19838	310454.78
MIRELF VII US SECURITIES LLC Harborside 3, 210 Hudson St. Ste. 400 Jersey City NJ 07311	Common	09/15/2025	26600	416276.70
MIRELF VI REIT INVESTMENT II, LLC Harborside 3, 210 Hudson St. Ste. 400 Jersey City NJ 07311	Common	09/12/2025	79724	1272734.52
MIRELF VII US SECURITIES LLC Harborside 3, 210 Hudson St. Ste. 400 Jersey City NJ 07311	Common	09/12/2025	106897	1706531.26
MIRELF VII US SECURITIES LLC Harborside 3, 210 Hudson St. Ste. 400 Jersey City NJ 07311	Common	09/11/2025	114560	1840956.29
MIRELF VI REIT INVESTMENT II, LLC Harborside 3, 210 Hudson St. Ste. 400 Jersey City NJ 07311	Common	09/11/2025	85440	1373003.71
MIRELF VII US SECURITIES LLC Harborside 3, 210 Hudson St. Ste. 400 Jersey City NJ 07311	Common	09/10/2025	85920	1378491.89
MIRELF VI REIT INVESTMENT II, LLC Harborside 3, 210 Hudson St. Ste. 400 Jersey City NJ 07311	Common	09/10/2025	64080	1028093.11
MIRELF VI REIT INVESTMENT II, LLC Harborside 3, 210 Hudson St. Ste. 400 Jersey City NJ 07311	Common	09/09/2025	64080	1032924.74
MIRELF VII US SECURITIES LLC Harborside 3, 210 Hudson St. Ste. 400 Jersey City NJ 07311	Common	09/09/2025	85920	1384970.29

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 for VRE disclose about the proposed sale?

The Form 144 discloses a proposed sale of 20,097 common shares of VRE valued at $311,909.46, to be sold on 09/17/2025 via Morgan Stanley Smith Barney LLC on the NYSE.

How and when were the 20,097 shares acquired according to the filing?

The filing states the shares were acquired in an open market purchase on 11/21/2018 with payment in cash on 11/23/2018.

Does the filing list recent sales of VRE shares by related entities?

Yes. The filing lists multiple sales in September 2025 by MIRELF VII US SECURITIES LLC and MIRELF VI REIT INVESTMENT II, LLC with individual sale sizes and gross proceeds for each transaction.

What representation does the seller make in the Remarks section?

The seller represents by signature that they do not know any material adverse information about the issuer that has not been publicly disclosed and notes the trading-plan disclosure instructions related to Rule 10b5-1.

Through which broker will the proposed sale be executed?

The proposed sale will be executed through Morgan Stanley Smith Barney LLC, address listed in the filing.